Selected research
Market Structure
Global Network Point-of-Care Glucose Testing Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Network Point-of-Care Glucose Testing Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Network Point-of-Care Glucose Testing Device include Johnson & Johnson, Trividia Health, Inc., Terumo, Roche Holding AG, Prodigy Diabetes Care, Panasonic Healthcare Holdings, Omron, Nova Biomedical and Nipro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Network Point-of-Care Glucose Testing Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Network Point-of-Care Glucose Testing Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Network Point-of-Care Glucose Testing Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Network Point-of-Care Glucose Testing Device market size, projected growth trends, production technologies, key applications, and end-use industries.
Network Point-of-Care Glucose Testing Device Segment by Company
Johnson & Johnson
Trividia Health, Inc.
Terumo
Roche Holding AG
Prodigy Diabetes Care
Panasonic Healthcare Holdings
Omron
Nova Biomedical
Nipro
LifeScan, Inc.
EKF Diagnostics
Danaher Corporation
B. Braun
Ascensia Diabetes Care Holdings AG
AgaMatrix
ACON Laboratories, Inc.
77 Elektronika
Network Point-of-Care Glucose Testing Device Segment by Type
0.5uL/0.6uL
1.5uL
1uL
Others
Network Point-of-Care Glucose Testing Device Segment by Application
Clinic
Hospital
Household
Network Point-of-Care Glucose Testing Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Network Point-of-Care Glucose Testing Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Network Point-of-Care Glucose Testing Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Network Point-of-Care Glucose Testing Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Network Point-of-Care Glucose Testing Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Network Point-of-Care Glucose Testing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Network Point-of-Care Glucose Testing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Network Point-of-Care Glucose Testing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Network Point-of-Care Glucose Testing Device Industry Trends
Table 2. Network Point-of-Care Glucose Testing Device Industry Drivers
Table 3. Network Point-of-Care Glucose Testing Device Industry Opportunities and Challenges
Table 4. Network Point-of-Care Glucose Testing Device Industry Restraints
Table 5. Global Network Point-of-Care Glucose Testing Device Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Network Point-of-Care Glucose Testing Device Sales by Manufacturers (k units) & (2021-2026)
Table 8. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Manufacturers
Table 9. Global Network Point-of-Care Glucose Testing Device Average Sales Price (USD/unit) of Manufacturers (2021-2026)
Table 10. Global Network Point-of-Care Glucose Testing Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Network Point-of-Care Glucose Testing Device Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Network Point-of-Care Glucose Testing Device Manufacturers, Product Type & Application
Table 13. Global Network Point-of-Care Glucose Testing Device Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Network Point-of-Care Glucose Testing Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of 0.5uL/0.6uL
Table 17. Major Manufacturers of 1.5uL
Table 18. Major Manufacturers of 1uL
Table 19. Major Manufacturers of Others
Table 20. Global Network Point-of-Care Glucose Testing Device Sales by Type 2021 VS 2025 VS 2032 (k units)
Table 21. Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2026) & (k units)
Table 22. Global Network Point-of-Care Glucose Testing Device Sales by Type (2027-2032) & (k units)
Table 23. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2021-2026)
Table 24. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2027-2032)
Table 25. Global Network Point-of-Care Glucose Testing Device Revenue by Type 2021 VS 2025 VS 2032 (k units)
Table 26. Global Network Point-of-Care Glucose Testing Device Revenue by Type (2021-2026) & (k units)
Table 27. Global Network Point-of-Care Glucose Testing Device Revenue by Type (2027-2032) & (k units)
Table 28. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2021-2026)
Table 29. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2027-2032)
Table 30. Major Manufacturers of Clinic
Table 31. Major Manufacturers of Hospital
Table 32. Major Manufacturers of Household
Table 33. Global Network Point-of-Care Glucose Testing Device Sales by Application 2021 VS 2025 VS 2032 (k units)
Table 34. Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2026) & (k units)
Table 35. Global Network Point-of-Care Glucose Testing Device Sales by Application (2027-2032) & (k units)
Table 36. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2021-2026)
Table 37. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2027-2032)
Table 38. Global Network Point-of-Care Glucose Testing Device Revenue by Application 2021 VS 2025 VS 2032 (k units)
Table 39. Global Network Point-of-Care Glucose Testing Device Revenue by Application (2021-2026) & (k units)
Table 40. Global Network Point-of-Care Glucose Testing Device Revenue by Application (2027-2032) & (k units)
Table 41. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2021-2026)
Table 42. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2027-2032)
Table 43. Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021 VS 2025 VS 2032 (k units)
Table 44. Global Network Point-of-Care Glucose Testing Device Sales by Region (2021-2026) & (k units)
Table 45. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2021-2026)
Table 46. Global Network Point-of-Care Glucose Testing Device Sales Forecasted by Region (2027-2032) & (k units)
Table 47. Global Network Point-of-Care Glucose Testing Device Sales Forecasted Market Share by Region (2027-2032)
Table 48. North America Network Point-of-Care Glucose Testing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 49. North America Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 50. North America Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 51. Europe Network Point-of-Care Glucose Testing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 52. Europe Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 53. Europe Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 54. Asia Pacific Network Point-of-Care Glucose Testing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 55. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 56. Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 57. South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 58. South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2021-2026) & (k units)
Table 59. South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2027-2032) & (k units)
Table 60. Global Network Point-of-Care Glucose Testing Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 61. Global Network Point-of-Care Glucose Testing Device Revenue by Region (2021-2026) & (US$ Million)
Table 62. Global Network Point-of-Care Glucose Testing Device Revenue by Region (2027-2032) & (US$ Million)
Table 63. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region (2021-2026)
Table 64. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region (2027-2032)
Table 65. Johnson & Johnson Company Information
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolio
Table 69. Johnson & Johnson Recent Development
Table 70. Trividia Health, Inc. Company Information
Table 71. Trividia Health, Inc. Business Overview
Table 72. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
Table 74. Trividia Health, Inc. Recent Development
Table 75. Terumo Company Information
Table 76. Terumo Business Overview
Table 77. Terumo Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Terumo Network Point-of-Care Glucose Testing Device Product Portfolio
Table 79. Terumo Recent Development
Table 80. Roche Holding AG Company Information
Table 81. Roche Holding AG Business Overview
Table 82. Roche Holding AG Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolio
Table 84. Roche Holding AG Recent Development
Table 85. Prodigy Diabetes Care Company Information
Table 86. Prodigy Diabetes Care Business Overview
Table 87. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolio
Table 89. Prodigy Diabetes Care Recent Development
Table 90. Panasonic Healthcare Holdings Company Information
Table 91. Panasonic Healthcare Holdings Business Overview
Table 92. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolio
Table 94. Panasonic Healthcare Holdings Recent Development
Table 95. Omron Company Information
Table 96. Omron Business Overview
Table 97. Omron Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Omron Network Point-of-Care Glucose Testing Device Product Portfolio
Table 99. Omron Recent Development
Table 100. Nova Biomedical Company Information
Table 101. Nova Biomedical Business Overview
Table 102. Nova Biomedical Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolio
Table 104. Nova Biomedical Recent Development
Table 105. Nipro Company Information
Table 106. Nipro Business Overview
Table 107. Nipro Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Nipro Network Point-of-Care Glucose Testing Device Product Portfolio
Table 109. Nipro Recent Development
Table 110. LifeScan, Inc. Company Information
Table 111. LifeScan, Inc. Business Overview
Table 112. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
Table 114. LifeScan, Inc. Recent Development
Table 115. EKF Diagnostics Company Information
Table 116. EKF Diagnostics Business Overview
Table 117. EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolio
Table 119. EKF Diagnostics Recent Development
Table 120. Danaher Corporation Company Information
Table 121. Danaher Corporation Business Overview
Table 122. Danaher Corporation Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolio
Table 124. Danaher Corporation Recent Development
Table 125. B. Braun Company Information
Table 126. B. Braun Business Overview
Table 127. B. Braun Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. B. Braun Network Point-of-Care Glucose Testing Device Product Portfolio
Table 129. B. Braun Recent Development
Table 130. Ascensia Diabetes Care Holdings AG Company Information
Table 131. Ascensia Diabetes Care Holdings AG Business Overview
Table 132. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolio
Table 134. Ascensia Diabetes Care Holdings AG Recent Development
Table 135. AgaMatrix Company Information
Table 136. AgaMatrix Business Overview
Table 137. AgaMatrix Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolio
Table 139. AgaMatrix Recent Development
Table 140. ACON Laboratories, Inc. Company Information
Table 141. ACON Laboratories, Inc. Business Overview
Table 142. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
Table 144. ACON Laboratories, Inc. Recent Development
Table 145. 77 Elektronika Company Information
Table 146. 77 Elektronika Business Overview
Table 147. 77 Elektronika Network Point-of-Care Glucose Testing Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolio
Table 149. 77 Elektronika Recent Development
Table 150. Key Raw Materials
Table 151. Raw Materials Key Suppliers
Table 152. Network Point-of-Care Glucose Testing Device Distributors List
Table 153. Network Point-of-Care Glucose Testing Device Customers List
Table 154. Research Programs/Design for This Report
Table 155. Authors List of This Report
Table 156. Secondary Sources
Table 157. Primary Sources
List of Figures
Figure 1. Network Point-of-Care Glucose Testing Device Product Image
Figure 2. Global Network Point-of-Care Glucose Testing Device Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Network Point-of-Care Glucose Testing Device Market Size (2021-2032) & (US$ Million)
Figure 4. Global Network Point-of-Care Glucose Testing Device Sales (2021-2032) & (k units)
Figure 5. Global Network Point-of-Care Glucose Testing Device Average Price (USD/unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Network Point-of-Care Glucose Testing Device Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. 0.5uL/0.6uL Image
Figure 9. 1.5uL Image
Figure 10. 1uL Image
Figure 11. Others Image
Figure 12. Global Network Point-of-Care Glucose Testing Device Sales by Type (2021 VS 2025 VS 2032) & (k units)
Figure 13. Global Network Point-of-Care Glucose Testing Device Sales Market Share 2021 VS 2025 VS 2032
Figure 14. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2021-2032)
Figure 15. Global Network Point-of-Care Glucose Testing Device Revenue by Type (2021 VS 2025 VS 2032) & (k units)
Figure 16. Global Network Point-of-Care Glucose Testing Device Revenue Market Share 2021 VS 2025 VS 2032
Figure 17. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2021-2032)
Figure 18. Clinic Image
Figure 19. Hospital Image
Figure 20. Household Image
Figure 21. Global Network Point-of-Care Glucose Testing Device Sales by Application (2021 VS 2025 VS 2032) & (k units)
Figure 22. Global Network Point-of-Care Glucose Testing Device Sales Market Share 2021 VS 2025 VS 2032
Figure 23. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2021-2032)
Figure 24. Global Network Point-of-Care Glucose Testing Device Revenue by Application (2021 VS 2025 VS 2032) & (k units)
Figure 25. Global Network Point-of-Care Glucose Testing Device Revenue Market Share 2021 VS 2025 VS 2032
Figure 26. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2021-2032)
Figure 27. North America Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 28. North America Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 29. U.S. Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 30. Canada Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 31. Mexico Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 32. Europe Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 33. Europe Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 34. Germany Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 35. France Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 36. U.K. Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 37. Italy Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 38. Netherlands Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 39. Asia Pacific Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 40. Asia Pacific Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 41. China Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 42. Japan Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 43. South Korea Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 44. Southeast Asia Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 45. India Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 46. Australia Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 47. South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 48. South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2021-2032)
Figure 49. Brazil Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 50. South Africa Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 51. Saudi Arabia Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 52. Turkey Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 53. Argentina Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 54. UAE Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 55. Egypt Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 56. Chile Network Point-of-Care Glucose Testing Device Sales and Growth Rate (2021-2032) & (k units)
Figure 57. Global Network Point-of-Care Glucose Testing Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 59. North America Network Point-of-Care Glucose Testing Device Revenue (2021-2032) & (US$ Million)
Figure 60. North America Network Point-of-Care Glucose Testing Device Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 61. Europe Network Point-of-Care Glucose Testing Device Revenue (2021-2032) & (US$ Million)
Figure 62. Europe Network Point-of-Care Glucose Testing Device Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 63. Asia-Pacific Network Point-of-Care Glucose Testing Device Revenue (2021-2032) & (US$ Million)
Figure 64. Asia-Pacific Network Point-of-Care Glucose Testing Device Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 65. South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue (2021-2032) & (US$ Million)
Figure 66. South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 67. Network Point-of-Care Glucose Testing Device Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Network Point-of-Care Glucose Testing Device Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
Scope & coverage.
Types
- 0.5uL/0.6uL
- 1.5uL
- 1uL
- Others
Applications
- Clinic
- Hospital
- Household
Companies covered
- Johnson & Johnson
- Trividia Health, Inc.
- Terumo
- Roche Holding AG
- Prodigy Diabetes Care
- Panasonic Healthcare Holdings
- Omron
- Nova Biomedical
- Nipro
- LifeScan, Inc.
- EKF Diagnostics
- Danaher Corporation
- B. Braun
- Ascensia Diabetes Care Holdings AG
- AgaMatrix
- ACON Laboratories, Inc.
- 77 Elektronika
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Network Point-of-Care Glucose Testing Device Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Network Point-of-Care Glucose Testing Device Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Network Point-of-Care Glucose Testing Device Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Network Point-of-Care Glucose Testing Device Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Network Point-of-Care Glucose Testing Device Market Dynamics
- 2.1 Network Point-of-Care Glucose Testing Device Industry Trends
- 2.2 Network Point-of-Care Glucose Testing Device Industry Drivers
- 2.3 Network Point-of-Care Glucose Testing Device Industry Opportunities and Challenges
- 2.4 Network Point-of-Care Glucose Testing Device Industry Restraints
3 Network Point-of-Care Glucose Testing Device Market by Manufacturers
- 3.1 Global Network Point-of-Care Glucose Testing Device Revenue by Manufacturers (2021-2026)
- 3.2 Global Network Point-of-Care Glucose Testing Device Sales by Manufacturers (2021-2026)
- 3.3 Global Network Point-of-Care Glucose Testing Device Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Network Point-of-Care Glucose Testing Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Network Point-of-Care Glucose Testing Device Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Network Point-of-Care Glucose Testing Device Manufacturers, Product Type & Application
- 3.7 Global Network Point-of-Care Glucose Testing Device Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Network Point-of-Care Glucose Testing Device Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Network Point-of-Care Glucose Testing Device Players Market Share by Revenue in 2025
- 3.8.3 2025 Network Point-of-Care Glucose Testing Device Tier 1, Tier 2, and Tier 3
4 Network Point-of-Care Glucose Testing Device Market by Type
- 4.1 Network Point-of-Care Glucose Testing Device Type Introduction
- 4.1.1 0.5uL/0.6uL
- 4.1.2 1.5uL
- 4.1.3 1uL
- 4.1.4 Others
- 4.2 Global Network Point-of-Care Glucose Testing Device Sales by Type
- 4.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2032)
- 4.2.3 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2021-2032)
- 4.3 Global Network Point-of-Care Glucose Testing Device Revenue by Type
- 4.3.1 Global Network Point-of-Care Glucose Testing Device Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Network Point-of-Care Glucose Testing Device Revenue by Type (2021-2032)
- 4.3.3 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2021-2032)
5 Network Point-of-Care Glucose Testing Device Market by Application
- 5.1 Network Point-of-Care Glucose Testing Device Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Household
- 5.2 Global Network Point-of-Care Glucose Testing Device Sales by Application
- 5.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2032)
- 5.2.3 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2021-2032)
- 5.3 Global Network Point-of-Care Glucose Testing Device Revenue by Application
- 5.3.1 Global Network Point-of-Care Glucose Testing Device Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Network Point-of-Care Glucose Testing Device Revenue by Application (2021-2032)
- 5.3.3 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2021-2032)
6 Global Network Point-of-Care Glucose Testing Device Sales by Region
- 6.1 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Network Point-of-Care Glucose Testing Device Sales by Region (2021-2032)
- 6.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Region (2021-2026)
- 6.2.2 Global Network Point-of-Care Glucose Testing Device Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Network Point-of-Care Glucose Testing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Network Point-of-Care Glucose Testing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Network Point-of-Care Glucose Testing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Network Point-of-Care Glucose Testing Device Revenue by Region
- 7.1 Global Network Point-of-Care Glucose Testing Device Revenue by Region
- 7.1.1 Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Network Point-of-Care Glucose Testing Device Revenue by Region (2021-2026)
- 7.1.3 Global Network Point-of-Care Glucose Testing Device Revenue by Region (2027-2032)
- 7.1.4 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Network Point-of-Care Glucose Testing Device Revenue (2021-2032)
- 7.2.2 North America Network Point-of-Care Glucose Testing Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Network Point-of-Care Glucose Testing Device Revenue (2021-2032)
- 7.3.2 Europe Network Point-of-Care Glucose Testing Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Network Point-of-Care Glucose Testing Device Revenue (2021-2032)
- 7.4.2 Asia-Pacific Network Point-of-Care Glucose Testing Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Johnson & Johnson
- 8.1.1 Johnson & Johnson Company Information
- 8.1.2 Johnson & Johnson Business Overview
- 8.1.3 Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.1.5 Johnson & Johnson Recent Developments
- 8.2 Trividia Health, Inc.
- 8.2.1 Trividia Health, Inc. Company Information
- 8.2.2 Trividia Health, Inc. Business Overview
- 8.2.3 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.2.5 Trividia Health, Inc. Recent Developments
- 8.3 Terumo
- 8.3.1 Terumo Company Information
- 8.3.2 Terumo Business Overview
- 8.3.3 Terumo Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Terumo Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.3.5 Terumo Recent Developments
- 8.4 Roche Holding AG
- 8.4.1 Roche Holding AG Company Information
- 8.4.2 Roche Holding AG Business Overview
- 8.4.3 Roche Holding AG Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.4.5 Roche Holding AG Recent Developments
- 8.5 Prodigy Diabetes Care
- 8.5.1 Prodigy Diabetes Care Company Information
- 8.5.2 Prodigy Diabetes Care Business Overview
- 8.5.3 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.5.5 Prodigy Diabetes Care Recent Developments
- 8.6 Panasonic Healthcare Holdings
- 8.6.1 Panasonic Healthcare Holdings Company Information
- 8.6.2 Panasonic Healthcare Holdings Business Overview
- 8.6.3 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.6.5 Panasonic Healthcare Holdings Recent Developments
- 8.7 Omron
- 8.7.1 Omron Company Information
- 8.7.2 Omron Business Overview
- 8.7.3 Omron Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Omron Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.7.5 Omron Recent Developments
- 8.8 Nova Biomedical
- 8.8.1 Nova Biomedical Company Information
- 8.8.2 Nova Biomedical Business Overview
- 8.8.3 Nova Biomedical Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.8.5 Nova Biomedical Recent Developments
- 8.9 Nipro
- 8.9.1 Nipro Company Information
- 8.9.2 Nipro Business Overview
- 8.9.3 Nipro Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Nipro Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.9.5 Nipro Recent Developments
- 8.10 LifeScan, Inc.
- 8.10.1 LifeScan, Inc. Company Information
- 8.10.2 LifeScan, Inc. Business Overview
- 8.10.3 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.10.5 LifeScan, Inc. Recent Developments
- 8.11 EKF Diagnostics
- 8.11.1 EKF Diagnostics Company Information
- 8.11.2 EKF Diagnostics Business Overview
- 8.11.3 EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.11.5 EKF Diagnostics Recent Developments
- 8.12 Danaher Corporation
- 8.12.1 Danaher Corporation Company Information
- 8.12.2 Danaher Corporation Business Overview
- 8.12.3 Danaher Corporation Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.12.5 Danaher Corporation Recent Developments
- 8.13 B. Braun
- 8.13.1 B. Braun Company Information
- 8.13.2 B. Braun Business Overview
- 8.13.3 B. Braun Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 B. Braun Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.13.5 B. Braun Recent Developments
- 8.14 Ascensia Diabetes Care Holdings AG
- 8.14.1 Ascensia Diabetes Care Holdings AG Company Information
- 8.14.2 Ascensia Diabetes Care Holdings AG Business Overview
- 8.14.3 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.14.5 Ascensia Diabetes Care Holdings AG Recent Developments
- 8.15 AgaMatrix
- 8.15.1 AgaMatrix Company Information
- 8.15.2 AgaMatrix Business Overview
- 8.15.3 AgaMatrix Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.15.5 AgaMatrix Recent Developments
- 8.16 ACON Laboratories, Inc.
- 8.16.1 ACON Laboratories, Inc. Company Information
- 8.16.2 ACON Laboratories, Inc. Business Overview
- 8.16.3 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.16.5 ACON Laboratories, Inc. Recent Developments
- 8.17 77 Elektronika
- 8.17.1 77 Elektronika Company Information
- 8.17.2 77 Elektronika Business Overview
- 8.17.3 77 Elektronika Network Point-of-Care Glucose Testing Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolio
- 8.17.5 77 Elektronika Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Network Point-of-Care Glucose Testing Device Value Chain Analysis
- 9.1.1 Network Point-of-Care Glucose Testing Device Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Network Point-of-Care Glucose Testing Device Production Mode & Process
- 9.2 Network Point-of-Care Glucose Testing Device Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Network Point-of-Care Glucose Testing Device Distributors
- 9.2.3 Network Point-of-Care Glucose Testing Device Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst